AMRX - Amneal Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

AMRX is currently covered by 6 analysts with an average price target of $24. This is a potential upside of $2.88 (13.64%) from yesterday's end of day stock price of $21.12.

Our record on Amneal Pharmaceuticals covers 18 analysts since 2008; 4 cover it today. Of the 84 price targets those analysts set on AMRX, 73 were reached (87%). The highest performance score on Amneal Pharmaceuticals belongs to David Amsellem of Piper Sandler: 3.22, with 11 of 11 targets met in 339 days on average. The latest calls: Chris Schott of JPMorgan raised the target to $25 from $24 with a Buy rating on 4 Nov 2026; Les Sulewski of Oppenheimer raised the target to $27 from $17 with a Buy rating on 23 Sep 2026; Glen Santangelo of Barclays raised the target to $20 from $16 with a Buy rating on 17 Sep 2026. Figures as of 18 Nov 2026.

Amneal Pharmaceuticals's activity chart (see below) currently has 99 price targets and 92 ratings on display. The stock rating distribution of AMRX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 77.72% of the time, taking 522 days on average.

Highest price target for AMRX is $27, Lowest price target is $20, average price target is $24.

Most recent stock forecast was given by DANIEL CLARK from LEERINK on 05-Nov-2026. First documented stock forecast 08-May-2018.

Currently out of the existing stock ratings of AMRX, 16 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 09-Sep-2026

$25

$3.88 (18.37%)

$23

17 days ago
(05-Nov-2026)

0/2 (0%)

$5.55 (28.53%)

Buy Since 22-Oct-2026

$25

$3.88 (18.37%)

$24

18 days ago
(04-Nov-2026)

0/2 (0%)

$5.05 (25.31%)

Buy Since 17-Apr-2026

$25

$3.88 (18.37%)

$25

1 months 21 days ago
(01-Oct-2026)

1/4 (25%)

$4.93 (24.56%)

103

Buy Since 03-May-2024

$27

$5.88 (27.84%)

$17

1 months 30 days ago
(23-Sep-2026)

8/9 (88.89%)

$7.67 (39.68%)

158

Buy Since 09-Dec-2025

$20

$-1.12 (-5.30%)

$16

2 months 5 days ago
(17-Sep-2026)

3/3 (100%)

$1.72 (9.41%)

32

Show more analysts

Please expand the browser size to see the chart

What is AMRX (Amneal Pharmaceuticals) average time for price targets to be met?

On average it took 522 days for the stock forecasts to be reached, with an average price target met ratio of 77.72%.

Which analyst most recently updated their price target on AMRX (Amneal Pharmaceuticals)?

Daniel Clark

Which analyst has the most public recommendations on AMRX (Amneal Pharmaceuticals)?

Daniel Clark works at LEERINK and has 7 price targets and 5 ratings on AMRX

Which analyst is the currently most bullish on AMRX (Amneal Pharmaceuticals)?

Les Sulewski with the highest potential upside of $5.88

Which analyst is the currently most reserved on AMRX (Amneal Pharmaceuticals)?

Randall Stanicky with the lowest potential downside of -$17.12
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?